Medicare Part D plans cover popular obesity drugs if they are used for an additional medically accepted purpose as approved ...

Medicare released its next target list of 15 drugs to negotiate prices of, including Novo Nordisk's blockbuster GLP-1 drugs.

Biotech stocks have slumped 15% since Donald Trump won his second presidency. That's because Trump comes with a lot of ...

Announcing the 15 medicines chosen for the second round of negotiations is one of the Biden administration’s final health ...

In a report released today, Mathieu Chevrier from Citi maintained a Hold rating on Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs ...